307 related articles for article (PubMed ID: 31404868)
1. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.
Ban C; Jo M; Park YH; Kim JH; Han JY; Lee KW; Kweon DH; Choi YJ
Food Chem; 2020 Jan; 302():125328. PubMed ID: 31404868
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
3. Control of the gastrointestinal digestion of solid lipid nanoparticles using PEGylated emulsifiers.
Ban C; Jo M; Lim S; Choi YJ
Food Chem; 2018 Jan; 239():442-452. PubMed ID: 28873589
[TBL] [Abstract][Full Text] [Related]
4. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
5. Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcumin.
Sun S; Du X; Fu M; Khan AR; Ji J; Liu W; Zhai G
Int J Pharm; 2021 Feb; 595():120227. PubMed ID: 33484915
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
8. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
9. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
Baek JS; Cho CW
Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
[TBL] [Abstract][Full Text] [Related]
10. Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability.
Kang X; Chen H; Li S; Jie L; Hu J; Wang X; Qi J; Ying X; Du Y
Colloids Surf B Biointerfaces; 2018 Jan; 161():597-605. PubMed ID: 29156336
[TBL] [Abstract][Full Text] [Related]
11. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles.
Wang W; Zhu R; Xie Q; Li A; Xiao Y; Li K; Liu H; Cui D; Chen Y; Wang S
Int J Nanomedicine; 2012; 7():3667-77. PubMed ID: 22888226
[TBL] [Abstract][Full Text] [Related]
12. Enhanced oral delivery and anti-gastroesophageal reflux activity of curcumin by binary mixed micelles.
Sun Y; Li Y; Shen Y; Wang J; Tang J; Zhao Z
Drug Dev Ind Pharm; 2019 Sep; 45(9):1444-1450. PubMed ID: 31170849
[TBL] [Abstract][Full Text] [Related]
13. Submicron complex lipid carriers for curcumin delivery to intestinal epithelial cells: Effect of different emulsifiers on bioaccessibility and cell uptake.
Yucel C; Quagliariello V; Iaffaioli RV; Ferrari G; Donsì F
Int J Pharm; 2015 Oct; 494(1):357-69. PubMed ID: 26291881
[TBL] [Abstract][Full Text] [Related]
14. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
Chen CC; Tsai TH; Huang ZR; Fang JY
Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
[TBL] [Abstract][Full Text] [Related]
15. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin.
Bapat P; Ghadi R; Chaudhari D; Katiyar SS; Jain S
Int J Pharm; 2019 Apr; 560():219-227. PubMed ID: 30776407
[TBL] [Abstract][Full Text] [Related]
16. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.
Cho HJ; Park JW; Yoon IS; Kim DD
Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
18. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.
Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y
Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557
[TBL] [Abstract][Full Text] [Related]
19. Curcumin Containing PEGylated Solid Lipid Nanoparticles for Systemic Administration: A Preliminary Study.
Santonocito D; Sarpietro MG; Carbone C; Panico A; Campisi A; Siciliano EA; Sposito G; Castelli F; Puglia C
Molecules; 2020 Jun; 25(13):. PubMed ID: 32629951
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
